NCT05550675

Brief Summary

This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as the importance of abnormalities identified by 3D high resolution anorectal manometry (HARM) will be compared between subjects with feacal incontinence (FI), double incontinence (DI) and controls. Presence and severity of both FI and urinary incontinence (UI) will be evaluated by disease specific questionnaires. Measuring both disease severity and Quality of Life (QoL) is needed to determine the true impact of incontinence. Finally, the impact on quality of life will be compared between both groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
50mo left

Started Jun 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jun 2022Jul 2030

Study Start

First participant enrolled

June 8, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 22, 2022

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2030

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

5.1 years

First QC Date

August 12, 2022

Last Update Submit

December 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • compose a database of patients suffering from faecal or double incontinence

    a database will be created

    during inclusion visit

Secondary Outcomes (13)

  • Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence

    during inclusion visit

  • Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence

    during inclusion visit

  • Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence

    during inclusion visit

  • Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence

    during inclusion visit

  • Confirm the role of diarrhea as a major determinant of double incontinence vs faecal incontinence

    during inclusion visit

  • +8 more secondary outcomes

Study Arms (3)

Double incontinence

Other: Questionnaires

faecal incontinence

Other: Questionnaires

controls

Other: Questionnaires

Interventions

Disease specific questionnaires

Double incontinencecontrolsfaecal incontinence

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients referred for HARM for FI are eligible to enroll in the database.

You may qualify if:

  • Age \> 18 years;
  • Self-reported faecal incontinence.

You may not qualify if:

  • Impossibility to perform the anorectal manometry because of pain, stenosis or organic disease;
  • Active (peri)rectal inflammation, including abscess;
  • Pregnancy;
  • Inability to cooperate during the anorectal manometry
  • Impossibility to perform HARM due to pain, stenosis or organic disease;
  • Inability to complete the questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Brussel

Brussels, Brussels Capital, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

EncopresisUrinary Incontinence

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorElimination DisordersMental DisordersUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological Manifestations

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2022

First Posted

September 22, 2022

Study Start

June 8, 2022

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2030

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations